Genetic variation in fatty acid-binding protein-4 and peroxisome proliferator-activated receptor γ interactively influence insulin sensitivity and body composition in males

Metabolism: Clinical and Experimental

Volumn 53, Issue 3, 2004, Pages 303-309

  Damcott, Coleen M ^a   Moffett, Susan P ^b   Feingold, Eleanor ^b   Barmada, M Michael ^b   Marshall, Julie A ^b   Hamman, Richard F ^b   Ferrell, Robert E ^b  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

FATTY ACID BINDING PROTEIN; FATTY ACID BINDING PROTEIN 4; INSULIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; UNCLASSIFIED DRUG; CARRIER PROTEIN; CELL RECEPTOR; FABP4 PROTEIN, HUMAN; FABP4 PROTEIN, MOUSE; FABP7 PROTEIN, HUMAN; TRANSCRIPTION FACTOR; TUMOR PROTEIN; TUMOR SUPPRESSOR PROTEIN;

ADULT; ARTICLE; BODY COMPOSITION; ENERGY METABOLISM; EUROPEAN AMERICAN; FEMALE; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GLUCOSE HOMEOSTASIS; HISPANIC; HUMAN; INSULIN RESISTANCE; INSULIN SENSITIVITY; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NUCLEOTIDE SEQUENCE; OBESITY; POSITIVE FEEDBACK; PREDICTION; PRIORITY JOURNAL; PROTEIN FUNCTION; UNITED STATES; CAUCASIAN; COHORT ANALYSIS; GENETICS; GENOTYPE; HOMEOSTASIS; MUTATION; PHYSIOLOGY; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; BODY COMPOSITION; CARRIER PROTEINS; COHORT STUDIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FATTY ACID-BINDING PROTEINS; GENOTYPE; HISPANIC AMERICANS; HOMEOSTASIS; HUMANS; INSULIN RESISTANCE; MALE; MUTATION; NEOPLASM PROTEINS; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, CYTOPLASMIC AND NUCLEAR; TRANSCRIPTION FACTORS; TUMOR SUPPRESSOR PROTEINS; UNITED STATES;

EID: 1842610797     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2003.10.010     Document Type: Article

References (46)

1. Fajas L, Auboeuf D, Raspe E, et al: The organization, promoter analysis, and expression of the human PPARgamma gene. J Biol Chem 272:18779-18789, 1997
2. Kahn CR, Vicent D, Doria A: Genetics of non-insulin-dependent (type-II) diabetes mellitus. Annu Rev Med 47:509-531, 1996
3. Bernlohr DA, Simpson MA, Hertzel AV, et al: Intracellular lipid-binding proteins and their genes. Annu Rev Nutr 17:277-303, 1997
4. Glatz JF, Borchers T, Spener F, et al: Fatty acids in cell signalling: Modulation by lipid binding proteins. Prostaglandins Leukot Essent Fatty Acids 52:121-127, 1995
5. Kersten S, Desvergne B, Wahli W: Roles of PPARs in health and disease. Nature 405:421-424, 2000
6. Willson TM, Brown PJ, Sternbach DD, et al: The PPARs: From orphan receptors to drug discovery. J Med Chem 43:527-550, 2000
7. Sundvold H, Lien S: Identification of a novel peroxisome proliferator-activated receptor (PPAR) gamma promoter in man and transactivation by the nuclear receptor RORalphal. Biochem Biophys Res Commun 287:383-390, 2001
8. Motojima K, Passilly P, Peters JM, et al: Expression of putative fatty acid transporter genes are regulated by peroxisome proliferator-activated receptor alpha and gamma activators in a tissue- and inducer-specific manner. J Biol Chem 273:16710-16714, 1998
9. Schoonjans K, Staels B, Auwerx J: The peroxisome proliferator activated receptors (PPARS) and their effects on lipid metabolism and adipocyte differentiation. Biochim Biophys Acta 1302:93-109, 1996
10. Vidal-Puig AJ, Considine RV, Jimenez-Linan M, et al: Peroxisome proliferator-activated receptor gene expression in human tissues: Effects of obesity, weight loss, and regulation by insulin and glucocorticoids. J Clin Invest 99:2416-2422, 1997
11. Dreyer C, Keller H, Mahfoudi A, et al: Positive regulation of the peroxisomal beta-oxidation pathway by fatty acids through activation of peroxisome proliferator-activated receptors (PPAR). Biol Cell 77: 67-76, 1993
12. Helledie T, Antonius M, Sorensen RV, et al: Lipid-binding proteins modulate ligand-dependent trans- activation by peroxisome proliferator-activated receptors and localize to the nucleus as well as the cytoplasm. J Lipid Res 41:1740-1751, 2000
13. Tan NS, Shaw NS, Vinckenbosch N, et al: Selective cooperation between fatty acid binding proteins and peroxisome proliferator-activated receptors in regulating transcription. Mol Cell Biol 22:5114-5127, 2002
14. Juge-Aubry C, Pernin A, Favez T, et al: DNA binding properties of peroxisome proliferator-activated receptor subtypes on various natural peroxisome proliferator response elements: Importance of the 5′-flanking region. J Biol Chem 272:25252-25259, 1997
15. Yen CJ, Beamer BA, Negri C, et al: Molecular scanning of the human peroxisome proliferator activated receptor gamma (hPPAR gamma) gene in diabetic Caucasians: Identification of a Pro12Ala PPAR gamma 2 missense mutation. Biochem Biophys Res Commun 241:270-274, 1997
16. Masugi J, Tamori Y, Mori H, et al: Inhibitory effect of a proline-to-alanine substitution at codon 12 of peroxisome proliferator-activated receptor-gamma 2 on thiazolidinedione-induced adipogenesis. Biochem Biophys Res Commun 268:178-182, 2000
17. Stumvoll M, Wahl HG, Loblein K, et al: Pro12Ala polymorphism in the peroxisome proliferator-activated receptor-gamma2 gene is associated with increased antilipolytic insulin sensitivity. Diabetes 50:876-881, 2001
18. Beamer BA, Yen CJ, Andersen RE, et al: Association of the Pro12Ala variant in the peroxisome proliferator-activated receptor-gamma2 gene with obesity in two Caucasian populations. Diabetes 47:1806-1808, 1998
19. Cole SA, Mitchell BD, Hsueh WC, et al: The Pro12Ala variant of peroxisome proliferator-activated receptor-gamma2 (PPAR-gamma2) is associated with measures of obesity in Mexican Americans. Int J Obes Relat Metab Disord 24:522-524, 2000
20. Meirhaeghe A, Fajas L, Helbecque N, et al: Impact of the peroxisome proliferator activated receptor gamma2 Pro12Ala polymorphism on adiposity, lipids and non-insulin-dependent diabetes mellitus. Int J Obes Relat Metab Disord 24:195-199, 2000
21. Deeb SS, Fajas L, Nemoto M, et al: A Pro12Ala substitution in PPARgamma2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity. Nat Genet 20:284-287, 1998
22. Ek J, Urhammer SA, Sorensen TI, et al: Homozygosity of the Pro12Ala variant of the peroxisome proliferation-activated receptor-gamma2 (PPAR-gamma2): Divergent modulating effects on body mass index in obese and lean Caucasian men. Diabetologia 42:892-895, 1999
23. Mori Y, Kim-Motoyama H, Katakura T, et al: Effect of the Pro12Ala variant of the human peroxisome proliferator-activated receptor gamma 2 gene on adiposity, fat distribution, and insulin sensitivity in Japanese men. Biochem Biophys Res Commun 251:195-198, 1998
24. Altshuler D, Hirschhorn JN, Klannemark M, et al: The common PPARgamma Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes. Nat Genet 26:76-80, 2000
25. Hamman RF, Marshall JA, Baxter J, et al: Methods and prevalence of non-insulin-dependent diabetes mellitus in a biethnic Colorado population: The San Luis Valley Diabetes Study. Am J Epidemiol 129:295-311, 1989
26. Marshall JA, Grunwald GK, Donahoo WT, et al: Percent body fat and lean mass explain the gender difference in leptin: Analysis and interpretation of leptin in Hispanic and non-Hispanic white adults. Obes Res 8:543-552, 2000
27. Matthews DR, Hosker JP, Rudenski AS, et al: Homeostasis model assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412-419, 1985
28. Chen X, Levine L, Kwok PY: Fluorescence polarization in homogeneous nucleic acid analysis. Genome Res 9:492-498, 1999
29. Hartl D, Clark A: Principles of Population Genetics (ed 2). Sunderland, MA, Sinauer, 1989
30. Wingender E, Chen X, Hehl R, et al: TRANSFAC: An integrated system for gene expression regulation. Nucleic Acids Res 28: 316-319, 2000
31. Fajas L, Schoonjans K, Gelman L, et al: Regulation of peroxisome proliferator-activated receptor gamma expression by adipocyte differentiation and determination factor 1/sterol regulatory element binding protein 1: Implications for adipocyte differentiation and metabolism. Mol Cell Biol 19:5495-5503, 1999
32. Rocchi S, Auwerx J: Peroxisome proliferator-activated receptor-gamma: A versatile metabolic regulator. Ann Med 31:342-351, 1999
33. Schoonjans K, Martin G, Staels B, et al: Peroxisome proliferator-activated receptors, orphans with ligands and functions. Curr Opin Lipidol 8:159-166, 1997
34. Kim JB, Wright HM, Wright M, et al: ADD1/SREBP1 activates PPARgamma through the production of endogenous ligand. Proc Natl Acad Sci USA 95:4333-4337, 1998
35. Burczynski FJ, Fandrey S, Wang G, et al: Cytosolic fatty acid binding protein enhances rat hepatocyte [3H]palmitate uptake. Can J Physiol Pharmacol 77:896-901, 1999
36. Wolfrum C, Buhlmann C, Rolf B, et al: Variation of liver-type fatty acid binding protein content in the human hepatoma cell line HepG2 by peroxisome proliferators and antisense RNA affects the rate of fatty acid uptake. Biochim Biophys Acta 1437:194-201, 1999
37. Murphy EJ: L-FABP and 1-FABP expression increase NBD-stearate uptake and cytoplasmic diffusion in L cells. Am J Physiol 275:G244-249, 1998
38. Levy E, Menard D, Delvin E, et al: The polymorphism at codon 54 of the FABP2 gene increases fat absorption in human intestinal explants. J Biol Chem 276:39679-39684, 2001
39. Schaap FG, Binas B, Danneberg H, et al: Impaired long-chain fatty acid utilization by cardiac myocytes isolated from mice lacking the heart-type fatty acid binding protein gene. Circ Res 85:329-337, 1999
40. Baier LJ, Sacchettini JC, Knowler WC, et al: An amino acid substitution in the human intestinal fatty acid binding protein is associated with increased fatty acid binding, increased fat oxidation, and insulin resistance. J Clin Invest 95:1281-1287, 1995
41. Baier LJ, Bogardus C, Sacchettini JC: A polymorphism in the human intestinal fatty acid binding protein alters fatty acid transport across Caco-2 cells. J Biol Chem 271:10892-10896, 1996
42. Shaughnessy S, Smith ER, Kodukula S, et al: Adipocyte metabolism in adipocyte fatty acid binding protein knockout mice (aP2-/-) after short-term high-fat feedingFunctional compensation by the keratinocyte [correction of keritinocyte]fatty acid binding protein. Diabetes 49:904-911, 2000
43. Lei HH, Chen MH, Yang WS, et al: Peroxisome proliferator-activated receptor gamma 2 Pro12Ala gene variant is strongly associated with larger body mass in the Taiwanese. Metabolism 49:1267-1270, 2000
44. Hara K, Okada T, Tobe K, et al: The Pro12Ala polymorphism in PPAR gamma2 may confer resistance to type 2 diabetes. Biochem Biophys Res Commun 271:212-216, 2000
45. Douglas JA, Erdos MR, Watanabe RM, et al: The peroxisome proliferator-activated receptor-gamma2 Pro12Ala variant: Association with type 2 diabetes and trait differences. Diabetes 50:886-890, 2001
46. Hegele RA, Cao H, Harris SB, et al: Peroxisome proliferator-activated receptor-gamma2 P12A and type 2 diabetes in Canadian Oji-Cree. J Clin Endocrinol Metab 85:2014-2019, 2000